PT98169A - Processo para a preparacao de analogos de oligonucleotidos com ligacoes internucleotido 3'-3' ou 5'-5' terminais - Google Patents

Processo para a preparacao de analogos de oligonucleotidos com ligacoes internucleotido 3'-3' ou 5'-5' terminais

Info

Publication number
PT98169A
PT98169A PT98169A PT9816991A PT98169A PT 98169 A PT98169 A PT 98169A PT 98169 A PT98169 A PT 98169A PT 9816991 A PT9816991 A PT 9816991A PT 98169 A PT98169 A PT 98169A
Authority
PT
Portugal
Prior art keywords
ligacoes
oligonucleotid
analogs
preparation
internally closed
Prior art date
Application number
PT98169A
Other languages
English (en)
Other versions
PT98169B (pt
Inventor
Hannelore Rosch
Anja Frohlich
Jose Flavio Ramalho-Ortigao
Matthias Montenarh
Hartmut Seliger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PT98169A publication Critical patent/PT98169A/pt
Publication of PT98169B publication Critical patent/PT98169B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R15/00—Details of measuring arrangements of the types provided for in groups G01R17/00 - G01R29/00, G01R33/00 - G01R33/26 or G01R35/00
    • G01R15/14—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks
    • G01R15/18—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks using inductive devices, e.g. transformers
    • G01R15/186—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks using inductive devices, e.g. transformers using current transformers with a core consisting of two or more parts, e.g. clamp-on type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Power Engineering (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polyesters Or Polycarbonates (AREA)
PT98169A 1990-07-02 1991-07-01 Processo para a preparacao de analogos de oligonucleotidos com ligacoes internucleotido 3'-3' ou 5'-5' terminais PT98169B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4021019 1990-07-02

Publications (2)

Publication Number Publication Date
PT98169A true PT98169A (pt) 1993-09-30
PT98169B PT98169B (pt) 1998-12-31

Family

ID=6409497

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98169A PT98169B (pt) 1990-07-02 1991-07-01 Processo para a preparacao de analogos de oligonucleotidos com ligacoes internucleotido 3'-3' ou 5'-5' terminais

Country Status (22)

Country Link
US (1) US5750669A (pt)
EP (1) EP0464638B1 (pt)
JP (1) JP3186795B2 (pt)
KR (1) KR100200400B1 (pt)
AT (1) ATE151076T1 (pt)
AU (1) AU647143B2 (pt)
CA (1) CA2045891C (pt)
CZ (1) CZ285408B6 (pt)
DE (1) DE59108644D1 (pt)
DK (1) DK0464638T3 (pt)
ES (1) ES2099718T3 (pt)
FI (1) FI104177B1 (pt)
GR (1) GR3023432T3 (pt)
HU (1) HU215147B (pt)
IE (1) IE912309A1 (pt)
IL (1) IL98672A (pt)
NO (1) NO303018B1 (pt)
NZ (1) NZ238769A (pt)
PT (1) PT98169B (pt)
SK (1) SK279544B6 (pt)
TW (1) TW206232B (pt)
ZA (1) ZA915056B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223618A (en) * 1990-08-13 1993-06-29 Isis Pharmaceuticals, Inc. 4'-desmethyl nucleoside analog compounds
ATE151773T1 (de) * 1992-09-24 1997-05-15 Hoechst Ag Oligoribonucleotid- und ribozym-analoga mit terminalen 3'-3'-bzw.5'-5'-verknüpfungen
EP0691977B1 (en) * 1993-03-31 1997-11-26 Sanofi Oligonucleotides with amide linkages replacing phosphodiester linkages
US6015886A (en) * 1993-05-24 2000-01-18 Chemgenes Corporation Oligonucleotide phosphate esters
US6605708B1 (en) 1993-07-28 2003-08-12 Hybridon, Inc. Building blocks with carbamate internucleoside linkages and oligonucleotides derived therefrom
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US7309692B1 (en) * 1996-07-08 2007-12-18 Board Of Regents, The University Of Texas System Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en) * 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
CN1060177C (zh) * 1997-06-28 2001-01-03 中国科学院上海生物化学研究所 3′－单磷酸化寡核苷酸
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US20030180789A1 (en) * 1998-12-30 2003-09-25 Dale Roderic M.K. Arrays with modified oligonucleotide and polynucleotide compositions
US6087112A (en) * 1998-12-30 2000-07-11 Oligos Etc. Inc. Arrays with modified oligonucleotide and polynucleotide compositions
DE19935756A1 (de) * 1999-07-27 2001-02-08 Mologen Forschungs Entwicklung Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
DE19935303A1 (de) 1999-07-28 2001-02-08 Aventis Pharma Gmbh Oligonukleotide zur Inhibierung der Expression von humanem eg5
US6271360B1 (en) 1999-08-27 2001-08-07 Valigen (Us), Inc. Single-stranded oligodeoxynucleotide mutational vectors
EP1702983A3 (en) 2000-04-13 2007-01-10 Medical University of South Carolina Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
EP1289911A2 (en) * 2000-06-13 2003-03-12 Proligo LLC Universal solid supports for solid phase oligosynthesis and methods for their preparation and use
DE60132471T2 (de) * 2000-09-26 2009-01-15 Idera Pharmaceuticals, Inc., Cambridge Modulation der immunostimulatorischen aktivität von immunostimulierenden oligonukleotidanaloga durch positionelle chemische veränderungen
GB0114007D0 (en) * 2001-06-08 2001-08-01 Isis Innovation Oilgonucleotides
US7070933B2 (en) * 2001-09-28 2006-07-04 Gen-Probe Incorporated Inversion probes
WO2003061386A1 (en) * 2002-01-03 2003-07-31 Board Of Regents, The University Of Texas System Wt1 antisense oligos for the inhibition of breast cancer
US7741297B2 (en) * 2002-02-04 2010-06-22 Oncothyreon Inc. Immunostimulatory, covalently lipidated oligonucleotides
AU2003290596B2 (en) 2002-11-05 2011-05-12 Isis Pharmaceuticals, Inc. Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
WO2004044138A2 (en) 2002-11-05 2004-05-27 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
WO2005121372A2 (en) * 2004-06-03 2005-12-22 Isis Pharmaceuticals, Inc. Double strand compositions comprising differentially modified strands for use in gene modulation
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
CA2679750A1 (en) 2008-09-23 2010-03-23 Nexus Dx, Inc. Methods for detecting nucleic acids in a sample
EP2781523A1 (en) 2013-03-18 2014-09-24 Miltenyi Biotec GmbH Lipophilic oligonucleotide analogs
KR101323476B1 (ko) * 2013-06-12 2013-10-31 조선미 건물용 층간소음 방지재와 이를 이용한 층간소음 방지구조 및 그 시공 방법
LU92821B1 (en) 2015-09-09 2017-03-20 Mologen Ag Combination comprising immunostimulatory oligonucleotides
GB2542425A (en) 2015-09-21 2017-03-22 Mologen Ag Means for the treatment of HIV
AU2017248189B2 (en) * 2016-04-08 2021-04-29 Translate Bio, Inc. Multimeric coding nucleic acid and uses thereof
CN111050806A (zh) 2017-06-02 2020-04-21 波涛生命科学有限公司 寡核苷酸组合物及其使用方法
KR20210005057A (ko) * 2018-04-12 2021-01-13 웨이브 라이프 사이언시스 리미티드 올리고뉴클레오티드 조성물 및 이의 이용 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123610A (en) * 1977-03-09 1978-10-31 The United States Government Nucleic acid crosslinking agent and affinity inactivation of nucleic acids therewith
US4711955A (en) * 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
FR2540122B1 (fr) * 1983-01-27 1985-11-29 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
DE3332068A1 (de) * 1983-09-06 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von nukleosidalkyl-, aralkyl- und arylphosphoniten und -phosphonaten
US4795700A (en) * 1985-01-25 1989-01-03 California Institute Of Technology Nucleic acid probes and methods of using same
US5276019A (en) * 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
EP0406309A4 (en) * 1988-03-25 1992-08-19 The University Of Virginia Alumni Patents Foundation Oligonucleotide n-alkylphosphoramidates
AU5418290A (en) * 1989-03-31 1990-11-05 University Patents Inc. Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections

Also Published As

Publication number Publication date
EP0464638A3 (en) 1992-09-02
CA2045891A1 (en) 1992-01-03
HU215147B (hu) 2000-03-28
IE912309A1 (en) 1992-01-15
IL98672A (en) 1995-12-08
NZ238769A (en) 1993-11-25
IL98672A0 (en) 1992-07-15
ES2099718T3 (es) 1997-06-01
KR100200400B1 (ko) 1999-06-15
DE59108644D1 (de) 1997-05-07
JPH05222088A (ja) 1993-08-31
NO912585D0 (no) 1991-07-01
CS201491A3 (en) 1992-01-15
AU7947591A (en) 1992-01-02
PT98169B (pt) 1998-12-31
JP3186795B2 (ja) 2001-07-11
AU647143B2 (en) 1994-03-17
CA2045891C (en) 2003-07-22
NO912585L (no) 1992-01-03
FI104177B (fi) 1999-11-30
US5750669A (en) 1998-05-12
FI104177B1 (fi) 1999-11-30
FI913169A (fi) 1992-01-03
EP0464638A2 (de) 1992-01-08
NO303018B1 (no) 1998-05-18
SK279544B6 (sk) 1998-12-02
GR3023432T3 (en) 1997-08-29
HUT62010A (en) 1993-03-29
HU912215D0 (en) 1991-12-30
DK0464638T3 (da) 1997-10-13
CZ285408B6 (cs) 1999-08-11
EP0464638B1 (de) 1997-04-02
ZA915056B (en) 1992-03-25
KR920002625A (ko) 1992-02-28
TW206232B (pt) 1993-05-21
FI913169A0 (fi) 1991-06-28
ATE151076T1 (de) 1997-04-15

Similar Documents

Publication Publication Date Title
PT98169A (pt) Processo para a preparacao de analogos de oligonucleotidos com ligacoes internucleotido 3'-3' ou 5'-5' terminais
DK140996A (da) Fremgangsmåde til fremstilling af 2,3,4,5-tetraflour-6-alkyl-benzoesyreforbindelser
DE3889393D1 (de) Verfahren zur Herstellung von 2,2,6,6-Tetramethyl-4-piperidylaminen.
DE3887291D1 (de) Verfahren zur Herstellung von N,N'-Dimethyl-perylen-3,4,9,10-tetracarbonsäurediimid in hochdeckender Pigmentform.
FI98065B (fi) Menetelmiä valmistaa substituoituja 1,3-oksatiolaaneja, joilla on virustenvastaisia ominaisuuksia
DE3885366D1 (de) Verfahren zur Herstellung von Pyrrolo-(3,4-c)pyrrolen.
EP0354185A3 (en) Piperidine-triazine compounds for use as stabilizers for organic materials
DE59003791D1 (de) Verfahren zur Herstellung von 1,3,3-Trimethyl-5-oxo-cyclohexan-carbonitril.
IT1205727B (it) Composizione detergente liquida dotata di perfezionate proprieta' ammorbidenti
GR3004988T3 (pt)
DE69006911D1 (de) Verfahren zur Herstellung von 3,4-Dichloranilin.
OA07225A (fr) Diamides d'acide hydroxymalonique substitué, leur procédé de production et leur utilisation comme pesticides.
DE69019052D1 (de) Verfahren zur Herstellung von 2'Deoxy-5-trifluoromethyl-ss-uridin.
DE69010608D1 (de) Verfahren zur Herstellung von 1,1-Diarylethanen.
IT8621434A0 (it) Composti politriazinici contenenti gruppi piperidinilammidinici e loro impiego come stabilizzanti per polimeri.
DE59007022D1 (de) Verfahren zur kontinuierlichen Herstellung von Nylon 4,6.
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
ATE115139T1 (de) Verfahren zur herstellung von 2,4-diamino-6- piperidinyl-pyrimidin-3-n-oxid.
DE69009651D1 (de) Verfahren zur Herstellung von 3,4-Dihydrocumarinderivaten.
DE69011996D1 (de) Verfahren zur Herstellung von 1,4-Dihydroxy-2-arylnaphthoat.
DE69214982D1 (de) Verfahren zur Herstellung von 2',3'-dideoxy-2',3'-didehydronukleosiden
DE59004473D1 (de) Verfahren zur Herstellung von 4-Amino-1,2,4-triazol-5-onen.
IT8620124A0 (it) Composizione liquida e plimerizzabile adatta per laproduzione di vetri organici dotati di elevata resistenza all'abrasione.
DE68910806D1 (de) Verfahren zur Herstellung von 4,4'''-Dihydroxyquaterphenyl oder deren Derivaten.
NO884264L (no) 3'-azido-2',3'-dideoksyuridin-anti-retrovirus-blanding.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930415

FG3A Patent granted, date of granting

Effective date: 19980902

PC3A Transfer or assignment

Free format text: 20010322 AVENTIS PHARMA DEUTSCHLAND GMBH DE

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20130902